Evidence map›Paper›PMID 27276170›Full record

Trial reportPloS one2016

HIV Incidence Estimates Using the Limiting Antigen Avidity EIA Assay at Testing Sites in Kiev City, Ukraine: 2013-2014.

Ruth Simmons, Ruslan Malyuta, Nelli Chentsova, Iryna Karnets, Gary Murphy, Antonia Medoeva, Yuri Kruglov, Alexander Yurchenko, Andrew Copas, Kholoud Porter and 1 more

Abstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Tailored HIV programmes and universal health coverage.Bulletin of the World Health Organization · 2020
    Article
  5. Article
  6. A Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Sequences in Kiev: Findings Among Key Populations.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ruth SimmonsUniversity College London, London, United Kingdom.
Ruslan MalyutaPerinatal Prevention of AIDS Initiative, Odessa, Ukraine.
Nelli ChentsovaKyiv City AIDS Centre, Ukraine.
Iryna KarnetsKyiv City AIDS Centre, Ukraine.
Gary MurphyPublic Health England, London, United Kingdom.
Antonia MedoevaKyiv City AIDS Centre, Ukraine.
Yuri KruglovInstitute of Epidemiology, Kyiv, Ukraine.
Alexander YurchenkoKyiv City AIDS Centre, Ukraine.
Andrew CopasUniversity College London, London, United Kingdom.
Kholoud PorterUniversity College London, London, United Kingdom.
CASCADE Collaboration in EuroCoord

Funding

Medical Research Council MC_UU_12023/15
6 · The paper itself

Abstract

objectiveTo estimate HIV incidence and highlight the characteristics of persons at greatest risk of HIV in the Ukraine capital, Kiev.

methodResidual samples from newly-diagnosed persons attending the Kiev City AIDS Centre were tested for evidence of recent HIV infection using an avidity assay. Questions on possible risk factors for HIV acquisition and testing history were introduced. All persons (≥16yrs) presenting for an HIV test April'13-March'14 were included. Rates per 100,000 population were calculated using region-specific denominators.

resultsDuring the study period 6370 individuals tested for HIV. Of the 467 individuals newly-diagnosed with HIV, 21 had insufficient samples for LAg testing. Of the remaining 446, 39 (8.7%) were classified as recent with an avidity index <1.5ODn, 10 were reclassified as long-standing as their viral load was <1000 copies/mL, resulting in 29 (6.5%) recent HIV infections. The only independent predictor for a recent infection was probable route of exposure, with MSM more likely to present with a recent infection compared with heterosexual contact [Odds Ratio 8.86; 95%CI 2.65-29.60]. We estimated HIV incidence at 21.5 per 100,000 population, corresponding to 466 new infections. Using population estimates for MSM and PWID, incidence was estimated to be between 2289.6 and 6868.7/100,000 MSM, and 350.4 for PWID.

conclusionA high proportion of persons newly-infected remain undiagnosed, with MSM disproportionally affected with one in four newly-HIV-diagnosed and one in three recently-HIV-infected. Our findings should be used for targeted public health interventions and health promotion.

Indexed as

Antibody AffinityHIV-1HIV InfectionsAdolescentAdultAntigens, ViralEnzyme-Linked Immunosorbent AssayHIV AntibodiesHumansIncidenceUkraineAntigens, ViralHIV Antibodies

Identifiers

PMID27276170
PMCPMC4898716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.